Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
Department of Health and Human Services
This Notice of Funding Opportunity (NOFO) invites applications from clinical centers to participate in a consortium to test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of
Funding
Award size
$1M – $10M
Award ceiling
1000000
Type
Cooperative Agreement
Dates
Deadline
Next 90 days
Posted
06/08/2026
Closes
2026-10-09
Eligibility
Eligibility
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationNative American tribal governments (Federally recognized)Small businessesCity or township governmentsState governmentsFor profit organizations other than small businessesSpecial district governmentsPrivate institutions of higher educationPublic housing authorities/Indian housing authoritiesIndependent school districtsCounty governmentsNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationOthers (see text field entitled "Additional Information on Eligibility" for clarification)Public and State controlled institutions of higher education
Program
Funding area
Health - HL
Opportunity #
RFA-DK-27-121
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov